TP53 and ovarian carcinoma: We identified that a small-molecule compound called MCB-613 caused a rapid and sustained decrease in the level of the usually stable p53-R175H GOF mutant in the ovarian cancer cell line TYK-Nu (Fig. 1a, b and Supplementary Fig. 1A).